Oakworth Capital, Inc. Merck & Co., Inc. Transaction History

Oakworth Capital, Inc.

  • $1.44 Billion
  • Q3 2024

A detailed history of Oakworth Capital, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Oakworth Capital, Inc. holds 20,816 shares of MRK stock, worth $2.04 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
20,816
Previous 20,486 1.61%
Holding current value
$2.04 Million
Previous $2.54 Million 6.82%
% of portfolio
0.16%
Previous 0.19%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
BUY
$111.15 - $128.97 $36,679 - $42,560
330 Added 1.61%
20,816 $2.36 Million
Q2 2024

Jul 19, 2024
BUY
$123.8 - $132.96 $31,445 - $33,771
254 Added 1.26%
20,486 $2.54 Million
Q1 2024

Apr 22, 2024
BUY
$113.24 - $131.95 $112,787 - $131,422
996 Added 5.18%
20,232 $2.67 Million
Q4 2023

Jan 30, 2024
BUY
$100.18 - $109.02 $178,220 - $193,946
1,779 Added 10.19%
19,236 $2.1 Million
Q3 2023

Oct 31, 2023
SELL
$102.95 - $114.33 $18,428 - $20,465
-179 Reduced 1.01%
17,457 $1.8 Million
Q2 2023

Jul 28, 2023
BUY
$108.61 - $118.38 $43,661 - $47,588
402 Added 2.33%
17,636 $2.04 Million
Q1 2023

May 02, 2023
SELL
$102.94 - $114.86 $12,764 - $14,242
-124 Reduced 0.71%
17,234 $1.83 Million
Q4 2022

Feb 03, 2023
SELL
$87.44 - $112.11 $138,155 - $177,133
-1,580 Reduced 8.34%
17,358 $1.93 Million
Q3 2022

Oct 31, 2022
BUY
$84.53 - $94.96 $12,425 - $13,959
147 Added 0.78%
18,938 $1.63 Million
Q2 2022

Aug 05, 2022
SELL
$83.49 - $94.64 $10,436 - $11,830
-125 Reduced 0.66%
18,791 $1.71 Million
Q1 2022

Apr 11, 2022
SELL
$73.51 - $82.4 $106,736 - $119,644
-1,452 Reduced 7.13%
18,916 $1.55 Million
Q4 2021

Feb 07, 2022
BUY
$72.28 - $90.54 $77,484 - $97,058
1,072 Added 5.56%
20,368 $1.56 Million
Q3 2021

Nov 10, 2021
SELL
$71.68 - $78.83 $76,697 - $84,348
-1,070 Reduced 5.25%
19,296 $1.45 Million
Q2 2021

Jul 20, 2021
BUY
$70.31 - $77.77 $18,632 - $20,609
265 Added 1.32%
20,366 $1.58 Million
Q1 2021

Apr 30, 2021
BUY
$68.86 - $81.11 $185,302 - $218,267
2,691 Added 15.46%
20,101 $1.55 Million
Q4 2020

Feb 12, 2021
SELL
$71.77 - $79.65 $362,223 - $401,993
-5,047 Reduced 22.47%
17,410 $1.42 Million
Q3 2020

Nov 09, 2020
SELL
$73.18 - $82.95 $5,268 - $5,972
-72 Reduced 0.32%
22,457 $1.86 Million
Q2 2020

Aug 11, 2020
BUY
$70.42 - $80.13 $160,346 - $182,456
2,277 Added 11.24%
22,529 $1.74 Million
Q1 2020

May 07, 2020
BUY
$63.36 - $87.82 $62,536 - $86,678
987 Added 5.12%
20,252 $1.56 Million
Q4 2019

Jan 31, 2020
BUY
$77.58 - $87.54 $100,698 - $113,626
1,298 Added 7.22%
19,265 $1.71 Million
Q3 2019

Nov 13, 2019
SELL
$76.08 - $82.93 $646,680 - $704,905
-8,500 Reduced 32.12%
17,967 $1.51 Million
Q2 2019

Aug 02, 2019
SELL
$69.84 - $81.59 $55,033 - $64,292
-788 Reduced 2.89%
26,467 $2.22 Million
Q1 2019

May 06, 2019
SELL
$69.58 - $79.36 $1,948 - $2,222
-28 Reduced 0.1%
27,255 $2.27 Million
Q4 2018

Feb 13, 2019
BUY
$65.24 - $75.71 $11,873 - $13,779
182 Added 0.67%
27,283 $2.08 Million
Q3 2018

Oct 25, 2018
BUY
$57.69 - $67.84 $50,651 - $59,563
878 Added 3.35%
27,101 $1.92 Million
Q2 2018

Aug 07, 2018
SELL
$50.83 - $59.72 $42,443 - $49,866
-835 Reduced 3.09%
26,223 $1.59 Million
Q1 2018

May 09, 2018
BUY
$50.96 - $59.23 $136,063 - $158,144
2,670 Added 10.95%
27,058 $1.59 Million
Q4 2017

Jan 22, 2018
SELL
$51.62 - $61.64 $41,089 - $49,065
-796 Reduced 3.16%
24,388 $1.35 Million
Q3 2017

Nov 08, 2017
BUY
$58.67 - $63.13 $1.48 Million - $1.59 Million
25,184
25,184 $1.61 Million

Others Institutions Holding MRK

# of Institutions
3,827
Shares Held
1.87B
Call Options Held
15.6M
Put Options Held
13.7M
View Full List

About Merck & Co., Inc.

MRK Quotes by TradingView
  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $248B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Oakworth Capital, Inc. Portfolio

Follow Oakworth Capital, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oakworth Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oakworth Capital, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email